CIBC Private Wealth Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,488
Closed -$403K 1084
2020
Q4
$403K Buy
+3,488
New +$391K ﹤0.01% 815
2018
Q3
Sell
-35
Closed -$5K 1868
2018
Q2
$5K Buy
35
+33
+1,650% +$4.69K ﹤0.01% 1738
2018
Q1
$0 Buy
+2
New +$251 ﹤0.01% 2124

Other funds holding GWPH

CIBC Private Wealth Group's GWPH Position: Q1 2021 in Review

CIBC Private Wealth Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 3,488 shares — an estimated $403K sold.

CIBC Private Wealth Group first reported a position in GWPH in Q1 2018 and held it in 3 quarters. The position peaked at $403K in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • CIBC Private Wealth Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • CIBC Private Wealth Group sold 3,488 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $403K.
  • CIBC Private Wealth Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 3 quarters.
  • CIBC Private Wealth Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $403K in Q4 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on CIBC Private Wealth Group's 13F filing for Q1 2021, filed 12 May 2021.